FOXP3 and neoplasm: In addition, the upcoming possibilities to modify compounds with other small molecules, such as PROTACs, to specifically target FoxP3 degradation in tumor-infiltrating Tregs24,36 could be an alternative strategy to achieve higher selectivity and less toxicity.